Diverse Effects of Increasing Lisinopril Doses on Lipid Abnormalities in Chronic Nephropathies
Article 2003 en
Authors
PR
Piero Ruggenenti
NM
Naobumi Mise
RP
Roberto Pisoni
Abstract
1 min read
In chronic nephropathies, angiotensin converting enzyme inhibitor uptitration to maximum tolerated doses safely ameliorated hypertriglyceridemia by a direct, dose-dependent effect, and hypercholesterolemia through amelioration of the nephrotic syndrome, particularly in patients with more severe hypoalbuminemia.
Piero Ruggenenti, Annalisa Perna, Marcello Tonelli, Giacomina Loriga, Nicola Motterlini, Nadia Rubis, Franca Ledda, Stefano Rota, Andrea Satta, Antonio Granata, Giovanni Giorgio Battaglia, Francesco Cambareri, S. David, Flavio Gaspari, Nadia Stucchi, Sergio Carminati, Bogdan Ene‐Iordache, Paolo Cravedi, Giuseppe Remuzzi
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.